Skip to content

Menu

Register

This program was part of the 2026 edition (June 12–13, 2026). Discover the 2027 edition

PRE-CONGRESS COURSE

Pre-congress course: Pelvic and para-aortic lymphadenectomy (30 places)

ABOUT THE COURSE

Comprehensive training

This course was designed to offer a comprehensive, up-to-date and integrated experience in oncologic retroperitoneal surgery, focusing on the safe, standardized and reproducible execution of techniques that directly affect staging, therapeutic decisions and quality of care. Throughout the program, participants deepen their understanding of the anatomical and strategic foundations of the retroperitoneum and discuss, in light of the best available evidence, how to reduce technical variability, prevent complications and optimize perioperative outcomes.

Core course topics

  • Pelvic and para-aortic lymphadenectomy: indications, anatomical boundaries, dissection planes, critical safety points and quality criteria.
  • Sentinel lymph node mapping with fluorescence (ICG/NIR): case selection, technique, intraoperative interpretation, decision pathways and integration with pathology.
  • Surgical technologies and operative efficiency: advanced energy, hemostatic agents, visualization tools and how to select and use each tool with a focus on safety.
  • Complications and prevention: early recognition, risk reduction strategies, protocol-based management and a multidisciplinary approach.
  • Integration with medical oncology and pathology: how to align surgical and histopathological findings with planning for systemic therapies, targeted therapy and immunotherapy, when indicated.

ACTIVITIES

Course coordinators

Course coordination
  • Dra. Audrey Tsunoda
  • Dr. Evanius Garcia Wiermann

Guest faculty

Guest faculty

National and International Guests

OBJECTIVES

What you will learn

By the end of the course, participants will be able to:

  • Plan and perform pelvic and para-aortic lymphadenectomy by identifying anatomical landmarks, defining boundaries and using safe dissection strategies.
  • Perform and interpret sentinel lymph node mapping with ICG/NIR, applying decision pathways and standardizing interaction with pathology.
  • Select and use advanced energy, hemostatic agents and visualization tools rationally to reduce bleeding, improve ergonomics and increase safety.
  • Prevent, recognize and manage retroperitoneal complications (vascular, ureteral, lymphatic and neurological), integrating protocols and a multidisciplinary approach.
  • 2 DAYS OF IMMERSION
  • 8 FACULTY

IMMERSION

Schedule

  1. 08:00 – 08:20

    Scientific opening

    Dra. Audrey Tieko Tsunoda

  2. 08:20 – 09:20

    Updates on the endometrium and technologies that influence therapeutic decisions

    • ENDOMETRIUM 2026: WHAT REALLY CHANGED?
    • New ESGO, FIGO 2023–2025 and NCCN recommendations
    • Role of lymphadenectomy vs SLN at different risk levels
    • Impact of targeted therapies (lenvatinib, pembrolizumab) on surgical indications
    • LOW- AND INTERMEDIATE-RISK CERVICAL CANCER
    • SLN as the staging standard – latest evidence
    • Integration with radiotherapy and criteria for reducing radicality
    • How neoadjuvant immunotherapy may change the surgical role
    • EARLY AND ADVANCED OVARIAN CANCER
    • SLN as part of surgical staging
    • When to request oncogenetic assessment in ovarian cancer
    • Innovative treatments in ovarian cancer

  3. 09:20 – 10:00

    Fluorescence applied to surgical oncology

    • Optimizing the NIR signal in patients with high BMI
    • Advanced interpretation of drainage patterns
    • How to configure next-generation video towers (Olympus/Stryker/Storz)
    • Demonstration of video towers (Olympus VISERA ELITE III, Stryker 1688 AIM)
    • Discussion of NIR upgrades, sensors and filters.

  4. 10:00 – 10:20

    Discussion

  5. 10:20 – 11:00

    Advanced energy: evidence-based selection

    • Comparison of harmonic vs bipolar sealers vs hybrid devices
    • Strategies to reduce bleeding and operative time
    • How energy affects late complications (lymphocele, neuralgia)

  6. 11:00 – 11:30

    Advanced hemostasis

    • Absorbable hemostatic agents (oxidized cellulose, gelatin + thrombin)
    • Synthetic sealants and lymphocele prevention
    • Comparative evidence Sponsorship opportunity:
    • Floseal / Surgiflo / Tachosil / Vistaseal
    • Demonstration cases with short videos

  7. 11:30 – 12:00

    Advanced anatomy and preservation strategies

    • Lateral pelvic spaces
    • Vascular anatomy applied to lymphadenectomies
    • Autonomic innervation
    • Safe stopping of dissection in complex patients Technological integration: 3D models, surgical navigation, integration with simulation platforms

  8. 12:00 – 12:30

    Multidisciplinary tumor board

    • How to decide between SLN and complete lymphadenectomy
    • Integration with immunotherapy and targeted therapy
    • Live tumor board discussion: 2 real cases
    • Pharmaceutical companies (immunotherapy, targeted therapy, hormone therapy)

  9. 12:30 – 13:30

    Lunch

  10. 13:30 – 16:30

    Live surgery

  11. 16:30 – 17:00

    Discussion

  12. 17:30

    End of the theoretical course